Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | l(3)mbt-like 1 (Drosophila) | Starlite/ChEMBL | No references |
Homo sapiens | aldehyde dehydrogenase 1 family, member A1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Succinate-semialdehyde dehydrogenase [NADP+] dependent (SSDH) GabD1 | aldehyde dehydrogenase 1 family, member A1 | 501 aa | 456 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | suppression of tumorigenicity 18 protein | 0.0066 | 0.0283 | 0.0471 |
Loa Loa (eye worm) | phosphotyrosine protein phosphatase | 0.0186 | 0.439 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0057 | 0 | 0.5 |
Schistosoma mansoni | myelin transcription factor 1 myt1 | 0.0066 | 0.0283 | 0.0273 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0119 | 0.2094 | 0.4758 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0186 | 0.439 | 1 |
Echinococcus granulosus | aldehyde dehydrogenase mitochondrial | 0.0073 | 0.0547 | 0.0928 |
Echinococcus multilocularis | histone acetyltransferase MYST2 | 0.0066 | 0.0283 | 0.0471 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0186 | 0.439 | 0.5 |
Echinococcus granulosus | histone acetyltransferase MYST2 | 0.0066 | 0.0283 | 0.0471 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0186 | 0.439 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0119 | 0.2094 | 0.4758 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0547 | 0.0537 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.0283 | 0.0622 |
Echinococcus multilocularis | endonuclease exonuclease phosphatase | 0.0227 | 0.5794 | 1 |
Brugia malayi | C2-HC type zinc finger protein C.e-MyT1 | 0.0066 | 0.0283 | 0.0622 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0057 | 0 | 0.5 |
Leishmania major | aldehyde dehydrogenase, mitochondrial precursor | 0.0073 | 0.0547 | 1 |
Onchocerca volvulus | 0.0186 | 0.439 | 1 | |
Toxoplasma gondii | aldehyde dehydrogenase | 0.0073 | 0.0547 | 0.5 |
Echinococcus multilocularis | suppression of tumorigenicity 18 protein | 0.0066 | 0.0283 | 0.0471 |
Schistosoma mansoni | aldehyde dehydrogenase | 0.0073 | 0.0547 | 0.0537 |
Giardia lamblia | Low molecular weight protein-tyrosine-phosphatase | 0.0186 | 0.439 | 0.5 |
Trypanosoma brucei | low molecular weight protein tyrosine phosphatase, putative | 0.0057 | 0 | 0.5 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0186 | 0.439 | 1 |
Echinococcus multilocularis | aldehyde dehydrogenase, mitochondrial | 0.0073 | 0.0547 | 0.0928 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0119 | 0.2094 | 0.4758 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0186 | 0.439 | 1 |
Brugia malayi | Low molecular weight phosphotyrosine protein phosphatase containing protein | 0.0186 | 0.439 | 1 |
Mycobacterium ulcerans | phosphotyrosine protein phosphatase PtpA | 0.0186 | 0.439 | 1 |
Mycobacterium tuberculosis | Phosphotyrosine protein phosphatase PtpA (protein-tyrosine-phosphatase) (PTPase) (LMW phosphatase) | 0.0129 | 0.2434 | 1 |
Loa Loa (eye worm) | MBCTL1 | 0.0066 | 0.0283 | 0.0622 |
Echinococcus granulosus | endonuclease exonuclease phosphatase | 0.0227 | 0.5794 | 1 |
Trichomonas vaginalis | low molecular weight protein-tyrosine-phosphatase, putative | 0.0186 | 0.439 | 1 |
Entamoeba histolytica | protein tyrosine phosphatase, putative | 0.0186 | 0.439 | 0.5 |
Trichomonas vaginalis | low molecular weight protein tyrosine phosphatase, putative | 0.0186 | 0.439 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.1413 um | PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)] | ChEMBL. | No reference |
Potency (functional) | = 14.1254 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 18.526 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | = 22.3872 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.